Nanotechnology Update: Corporations Up Their Spending as Revenues for Nano-enabled Products Increase

February 17, 2014 | State of the Market Report

Governments, corporations, and private investors (venture capitalists) invested $18.5 billion in nanotechnology in 2012, increasing their spending 8% relative to 2010. The U.S. contributed 36% of this amount. Corporations expanded spending by 21% over 201o, while governments and private investors reduced their investments by 5% and 10% respectively. The United States maintained its lead over all other governments, with $2.1 billion of federal and state funding in 2012. U.S. corporations also led global spending on nanotechnology research and development, investing $4 billion in 2012, which was approximately $1 billion more than the next country, Japan. The revenue from nano-enabled products has continued to grow, from $339 billion in 2010 to $731 billion in 2012. This total is a slight decrease in our estimate relative to our last update on nano-enabled product revenues released in 2009. Our expanded forecast for nano-enabled products reveals the global value of nano-enabled products, nano-intermediates, and nanomaterials reaching $4.4 trillion by 2018.

Coverage Areas

  • Accelerating Materials Innovation
  • Nanotechnology

Table of Contents

  • Executive Summary
  • Nanotechnology Update
  • Endnotes

Login to View This Research

Already a Lux Client?

Sign In

Not a Lux Client?

Talk to Lux Research now and learn the benefits of becoming a member.

Lux Research

  • Helps clients find new business opportunities from emerging technologies in the physical and life sciences
  • Offers ongoing technology and market intelligence, as well as market data and consulting services
  • Now serves over 250 clients on six continents – multinational corporations, investors, governments, and SMEs
  • Has a Global reach, with offices in Boston, New York, Amsterdam, Singapore, and Tokyo
  • Combines deep technical expertise with business analysis to support strategic decisions

Or call us now

For North America (Boston Headquarters)
+1 (617) 502-5300

For EMEA (Amsterdam)
+31 (0) 20-3460840

For APAC (Singapore)
+65 6592-6978